Hera Biotech, Inc.
🇺🇸 San Antonio, Texas, USABiotechnology
Total raised
$2 M
1 round on record
Latest round
$2 M
Apr 2025
First round on record
Apr 2025
Today
Private
No later event on record
Funding rounds
1 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Apr 2025 | $2 M | No. 1 | Under $2 million | debt, options | SEC |
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Hera Biotech, Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2026).
SEC Form D · Sep 2026
The industry group it chose in its notices: Biotechnology.
SEC Form D · Sep 2026
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Hera Biotech, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Somer Baburek | Executive officer | Sep 2026 |
| Neal Walsdorf, Jr. | Director | Sep 2026 |
| Paul Castella | Director | Sep 2026 |
| Somer Baburek | Director | Sep 2026 |
| Teo Tijerina | Director | Sep 2026 |
| Wendy Smith | Director | Sep 2026 |